Take context from the input text and decide on the accurate relationship between 'Tabrecta' and 'Novartis' from the options provided.
Options: legal form, stock exchange, developer, manufacturer

Royalties from Novartis of $66 million for Jakavi and $1 million for Tabrecta and royalties from Lilly of $26 million for Olumiant.
manufacturer